IMAGE
Fig. 4
- ID
- ZDB-IMAGE-230906-11
- Publication
- Arias-Alpizar et al., 2022 - Phase-separated Liposomes Hijack Endogenous Lipoprotein Transport and Metabolism Pathways to Target Subsets of Endothelial Cells in vivo
- All Figures
- Figures for Arias-Alpizar et al., 2022
Image
|
Figure Caption
Fig. 4
bECs targeting by PAP3 liposomes is inhibited by heparin and an EL lipase inhibitor. a) Timeline of injection and imaging. b,c) Biodistribution (10x and 40x magnification) of PAP3 liposomes at 1.5 hpi, after heparin (1 nl, 50 mg ml−1) administration. d) Timeline of injection and imaging. e,f) Biodistribution (10x and 40x magnification) of PAP3 liposomes, as a reference, at 1.5 hpi. g) Timeline of injection and imaging. h,i) Biodistribution (10x and 40x magnification) of PAP3 liposomes at 1.5 hpi, after a double administration (24 and 1 h prior liposome injection) of an EL inhibitor (XEN445, 1 nL of 50 µM). All zebrafish larvae, Tg(kdrl:GFP) at ≈78 hpi. Liposomes (5 mM, 0.2% mol DOPE-LR) formulated by extrusion. Scale bars: 200 µm (whole embryo) and 50 µm (tissue level).
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Adv. Healthc. Mater.